Ftse Mib
34.387,08
-0,82%
DAX
18.469,05
-0,76%
S&P 500
5.283,40
0,11%
NASDAQ
16.828,67
0,00%
Bitcoin
69.007,32
0,30%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Enovis Corporation (ENOV) Enovis Corporation (ENOV) Notizie

ENOV

Enovis (ENOV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ENOV
DataOraFonteTitoloSimboloCompagnia
04/06/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENOVEnovis Corporation
31/05/202422:05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ENOVEnovis Corporation
22/05/202422:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENOVEnovis Corporation
10/05/202412:00GlobeNewswire Inc.Enovis to Participate in Upcoming Investor ConferencesNYSE:ENOVEnovis Corporation
02/05/202412:00GlobeNewswire Inc.Enovis Announces First Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
17/04/202413:00GlobeNewswire Inc.Enovis to Host First Quarter 2024 Results Conference Call on May 2ndNYSE:ENOVEnovis Corporation
28/03/202412:00GlobeNewswire Inc.Enovis to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNYSE:ENOVEnovis Corporation
22/02/202412:57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:ENOVEnovis Corporation
22/02/202412:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENOVEnovis Corporation
22/02/202412:00GlobeNewswire Inc.Enovis Announces Fourth Quarter and Full Year 2023 ResultsNYSE:ENOVEnovis Corporation
21/02/202422:48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:ENOVEnovis Corporation
14/02/202416:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENOVEnovis Corporation
12/02/202417:30GlobeNewswire Inc.Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual MeetingNYSE:ENOVEnovis Corporation
07/02/202422:15GlobeNewswire Inc.Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024NYSE:ENOVEnovis Corporation
29/01/202414:00GlobeNewswire Inc.Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual MeetingNYSE:ENOVEnovis Corporation
26/01/202412:00GlobeNewswire Inc.Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22ndNYSE:ENOVEnovis Corporation
25/01/202414:30GlobeNewswire Inc.Enovis Introduces the DonJoy ROAM™ OA Knee BraceNYSE:ENOVEnovis Corporation
11/01/202403:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ENOVEnovis Corporation
03/01/202412:00GlobeNewswire Inc.Enovis Completes Acquisition of LimaCorporate S.p.ANYSE:ENOVEnovis Corporation
28/12/202311:00GlobeNewswire Inc.Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:ENOVEnovis Corporation
05/12/202312:00GlobeNewswire Inc.Enovis Announces Business Segment Leadership Transition PlanNYSE:ENOVEnovis Corporation
16/11/202322:15GlobeNewswire Inc.Enovis to participate in the 6th Annual EverCore ISI HealthCONx ConferenceNYSE:ENOVEnovis Corporation
07/11/202312:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENOVEnovis Corporation
07/11/202312:00GlobeNewswire Inc.Enovis Announces Third Quarter 2023 Results and Raises Full-Year OutlookNYSE:ENOVEnovis Corporation
30/10/202313:00GlobeNewswire Inc.Enovis™ to Showcase New Surgical Innovations at AAHKS Annual MeetingNYSE:ENOVEnovis Corporation
20/10/202312:00GlobeNewswire Inc.ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028NYSE:ENOVEnovis Corporation
19/10/202312:58GlobeNewswire Inc.Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023NYSE:ENOVEnovis Corporation
19/10/202312:51GlobeNewswire Inc.Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior NotesNYSE:ENOVEnovis Corporation
16/10/202313:00GlobeNewswire Inc.Enovis to Host Third Quarter 2023 Results Conference Call on November 7thNYSE:ENOVEnovis Corporation
25/09/202314:17Dow Jones NewsEQT to Sell LimaCorporate to EnovisNYSE:ENOVEnovis Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ENOV

La tua Cronologia

BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
PST
Poste Italiane S.p.a
BIT
TEN
Tenaris
BIT
SRG
Snam
BIT
BAMI
Banco BPM
BIT
ARIS
Ariston Holding NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network